MetaCap

Bluejay Diagnostics (BJDX) vs INVO Fertility (IVF)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.

Summary

Bluejay Diagnostics is the larger company by market cap ($3.6 million vs $3.4 million), about 1.1 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

BJDX+0.68%IVF+0.35%
+1%+0%-0%
Oct 7, 20261 yearOct 8, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

BJDX versus IVF key metrics
MetricBJDXIVF
Share price$0.8156$0.7401
Market cap$3.64M$3.41M
1-day change+0.68%+0.35%
P/E ratio (TTM)—0.01
EPS (TTM)$-3.61$127.95
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$16.68$84.40
52-week low$0.755$0.711
Distance from 52-week high-95.11%-99.12%
Analyst consensus—none
Avg. price target upside—+2602.34%
Average volume3.81M2.16M
Shares outstanding4.47M4.60M
Employees640
SectorHealthcareHealthcare
IndustryMedical DevicesMedical Devices

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Bluejay Diagnostics

BJDX stock →

Bluejay Diagnostics, Inc. operates as a medical diagnostics company.

Healthcare · Medical Devices · 6 employees

About INVO Fertility

IVF stock →

INVO Fertility, Inc., a healthcare services company, focuses on the fertility marketplace that provides assisted reproductive technology care to patients. It operates through Fertility Clinic Services and INVOcell Device segments.

Healthcare · Medical Devices · 40 employees

BJDX vs IVF FAQ

Which is bigger, Bluejay Diagnostics or INVO Fertility?

Bluejay Diagnostics (BJDX) is larger, with a market capitalization of $3.64M compared with $3.41M for INVO Fertility (IVF).

Are Bluejay Diagnostics and INVO Fertility in the same industry?

Yes. Both are classified in the Medical Devices industry within the Healthcare sector.

More comparisons